Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Wearable Tissue Viability Diagnostic Unit, 30391 [06-4880]

Download as PDF Federal Register / Vol. 71, No. 102 / Friday, May 26, 2006 / Notices Office of the Secretary Strategic Environmental Research and Development Program, Scientific Advisory Board Department of Defense. Notice open meeting. AGENCY: ACTION: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–ZA–J, 504 Scott Street, Fort Detrick, Frederick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: A device for gathering image information about a region of tissue that has been exposed to a contrast agent and methods of use thereof. The device preferably includes night vision goggles, and an excitation source that generates light of a wavelength to activate the contrast agent. The excitation source preferably is attached to the night vision goggles and is capable of directing light to a target. A filter preferably is attached to the night vision goggles, wherein the filter passes light sufficient to form an image of the region of tissue, and wherein the image may be assessed to determine the viability of the region of tissue. ADDRESSES: DEPARTMENT OF DEFENSE SUMMARY: This Notice is published in accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463). The topic of the meeting on June 13–14, 2006 are to review new start and continuing research and development projects requesting Strategic Environmental Research and Development Program funds in excess of $1M. This meeting is open to the public. Any interested person may attend, appear before, or file statements with the Scientific Advisory Board at the time and in the manner permitted by the Board. DATES: June 13, 2006 from 8 a.m. to 12 p.m. and June 14, 2006 from 8 a.m. to 5 p.m. ADDRESSES: Battelle Eastern Science and Technology Center, 1204 Technology Drive, Aberdeen, MD 21001. FOR FURTHER INFORMATION CONTACT: Ms. Misa Jensen, SERDP Program Office, 901 North Stuart Street, Suite 303, Arlington, VA or by telephone at (703) 696-2126. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 06–4880 Filed 5–25–06; 8:45 am] BILLING CODE 3710–08–M C.R. Choate, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 06–4887 Filed 5–25–06; 8:45 am] DEPARTMENT OF DEFENSE BILLING CODE 5001–06–M Notice of Availability of a Draft Integrated System Investment Plan and Programmatic Environmental Impact Statement for the Ohio River Mainstem System Study Department of the Army; Corps of Engineers DEPARTMENT OF DEFENSE Department of the Army Department of the Army, U.S. Army Corps of Engineers, DoD. ACTION: Notice of availability. AGENCY: Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Wearable Tissue Viability Diagnostic Unit Department of the Army, DoD. Notice. AGENCY: jlentini on PROD1PC65 with NOTICES ACTION: SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 10/882,310 entitled ‘‘Wearable Tissue Viability Diagnostic Unit,’’ filed July 2, 2004. Foreign rights also available (PCT/ US04/021654). The United States Government, as represented by the Secretary of the Army, has rights in this invention. VerDate Aug<31>2005 16:12 May 25, 2006 Jkt 208001 SUMMARY: a. Pursuant to the National Environmental Policy Act (NEPA), the Great Lakes and Ohio River Division of the U.S. Army Corps of Engineers (Corps) is seeking comments on a draft System Investment Plan and Programmatic Environmental Impact Statement (SIP/PEIS) that evaluates alternative investment strategies for the maintenance of commercial navigation infrastructure along with the ecosystem sustainability needs on the Ohio River System for the next 60 years. b. The primary purpose of the Ohio River Mainstem Systems Study (ORMSS) is to develop the best SIP for maintaining safe, environmentally PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 30391 sustainable, and reliable navigation on the Ohio River over a 60-year period from 2010 to 2070. The study evaluated the operation and maintenance, rehabilitation, and construction reinvestment needs at the 19 navigation lock and dam sites on the Ohio River Mainstem. The study reports on five plans for meeting these needs based on five different traffic forecast scenarios. The future reliable operation of these structures is critical to the continued growth in commercial navigation throughout the Ohio River basin. In response to stakeholder input, the study purpose was modified to include the identification of measures to improve ecological sustainability to provide a balance between economic and environmental improvements. c. In order to facilitate review, the Corps will be conducting six public meetings along the Ohio River to solicit comments on its proposed plan. (See SUPPLEMENTARY INFORMATION for dates, times and locations). d. The Corps will be providing copies of the SIP/PEIS at numerous locations for review by the public. (See SUPPLEMENTARY INFORMATION for locations). e. The review and comment period for this draft document will be 60 days. DATES: Submit comments on or before July 25, 2006. ADDRESSES: Send all written comments and queries concerning this draft report to Mr. Jeffrey Benedict, U.S. Army Corps of Engineers, Pittsburgh District, William S. Morehead Building, 1000 Liberty Avenue, Pittsburgh, PA 15222– 4186. Telephone: (412) 395–7202. Electronic mail: celrlormss@lrl02.usace.army.mil. Fax: (412) 644–2673. FOR FURTHER INFORMATION CONTACT: Mr. Veronica Rife, U.S. Army Corps of Engineers, Louisville District, 600 Dr. Martin Luther King, Jr. Place, Louisville, KY 40202. Telephone: (502) 315–6785. Electronic mail: celrlormss@lrl02.usace.army.mil. SUPPLEMENTARY INFORMATION: 1. Authority: The proposed action is being conducted under the authority of United States Senate, Committee on Public Works resolution dated May 16, 1955; and United States House of Representatives, Committee on Public Works and Transportation resolution dated March 11, 1982. 2. Background: a. The ORMSS draft report is an integrated System Investment Plan (SIP) and Programmatic Environmental Impact Statement (PEIS). The PEIS is centered on a system-wide Cumulative Effects Assessment (CEA) and other studies that focused on E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 71, Number 102 (Friday, May 26, 2006)]
[Notices]
[Page 30391]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4880]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Wearable Tissue 
Viability Diagnostic Unit

AGENCY: Department of the Army, DoD.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
10/882,310 entitled ``Wearable Tissue Viability Diagnostic Unit,'' 
filed July 2, 2004. Foreign rights also available (PCT/US04/021654). 
The United States Government, as represented by the Secretary of the 
Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A device for gathering image information 
about a region of tissue that has been exposed to a contrast agent and 
methods of use thereof. The device preferably includes night vision 
goggles, and an excitation source that generates light of a wavelength 
to activate the contrast agent. The excitation source preferably is 
attached to the night vision goggles and is capable of directing light 
to a target. A filter preferably is attached to the night vision 
goggles, wherein the filter passes light sufficient to form an image of 
the region of tissue, and wherein the image may be assessed to 
determine the viability of the region of tissue.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 06-4880 Filed 5-25-06; 8:45 am]
BILLING CODE 3710-08-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.